The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 501–600 of 910
Kohno, M. (2017) · Food Science and Technology Research · doi:10.3136/fstr.23.773 · Cited by 8
Atorvastatin and insulin equally mitigate brain pathology in diabetic rats
Pratchayasakul, W., Thongnak, L., Chattipakorn, K., Lungaphin, A., Pongchaidecha, A., Satjaritanun, P., Jaiwongkam, T., Kerdphoo, S., & Chattipakorn, S. C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.01.021 · Cited by 7
Elseweidy, M. M., El-Swefy, S. E., Younis, N. N., & Tarek, S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04836-1 · Cited by 7
Ghadge, G. A., Gourishetti, K., Chamallamudi, M. R., Nampurath, G. K., Nandakumar, K., & Kumar, N. (2020) · 3 Biotech · doi:10.1007/s13205-020-2146-1 · Cited by 7
Liu, T. N., Wu, C., He, F., Yuan, W., Li, S. X., Li, H. W., Yu, H. Y., & Wu, M. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15028216 · Cited by 7
Itani, M., & Dubinsky, T. J. (2017) · Ultrasound Quarterly · doi:10.1097/ruq.0000000000000287 · Cited by 7
An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use
Mulchey, K., & Bshouty, Z. (2009) · Canadian Respiratory Journal · doi:10.1155/2009/958617 · Cited by 7
The Impact of Statin Use on Sepsis Mortality: A Systematic Review and Meta-Analysis
Philippou, C., Tsioutis, C., Tsiappari, M., Spernovasilis, N., Papadopoulos, D., & Agouridis, A. (2025) · Medicina · doi:10.3390/medicina61091563 · Cited by 7
Beyond cardiovascular health: The pharmacotherapeutic potential of statins in oncology
Abdelhamid, A., Nasrallah, D., Ahmed, E. A., Sahebkar, A., & Eid, A. H. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.10.003 · Cited by 7
Postdiagnosis Statin Use and Breast Cancer Mortality
Harborg, S., Pedersen, L. H., Sørensen, H. T., Ahern, T. P., Cronin-Fenton, D. P., & Borgquist, S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38737 · Cited by 6
A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
Mousa, E. A., Al-Azzam, S. I., Araydah, M., Karasneh, R. A., Ghnaimat, M. A., Al-Makhamreh, H. K., Khawaldeh, A., Al-Samen, M. A. A., HADDAD, J. A., Najjar, S. A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134312 · Cited by 8
Ideo, F., Manca, M. F., Niazi, S. A., Mannocci, F., Bardini, G., & Cotti, E. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03472-3 · Cited by 9
Individualized Dose-Response to Statins Associated With Cardiovascular Disease Outcomes
Aggarwal, S. K., Jiang, L., Liu, G., Grabowska, M. E., Ong, H. H., Wilke, R. A., Feng, Q., & Wei, W. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100894 · Cited by 6
de Mello, T. F., Goedert, A. B., de Souza, J. S. S., da Cruz, J. V. R., da Silva, A. S., Knorst, J. K., Müller, Y. M. R., Silva, F. R. M. B., & Leite, G. A. A. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108717 · Cited by 6
Desai, P. R., Mehta, P. J., Ojha, S. K., & Chokshi, A. B. (2017) · Acta Chromatographica · doi:10.1556/1326.2017.00273 · Cited by 6
Latest Updates on Lipid Management
Egom, E. E. A., Pharithi, R. B., Hesse, S., Starr, N., Armstrong, R. L., Sulaiman, H. M., Gazdíková, K., Mozos, I. M., Čaprnda, M., Kubatka, P., et al. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00306-8 · Cited by 5
Are KIF6 and APOE polymorphisms associated with power and endurance athletes?
Wojciechowicz, B., Laguette, M.-J. N., Sawczuk, M., Humińska‐Lisowska, K., Maciejewska, A., Ficek, K., Michałowska‐Sawczyn, M., Leońska‐Duniec, A., Kaczmarczyk, M., Chycki, J., et al. (2020) · European Journal of Sport Science · doi:10.1080/17461391.2020.1817983 · Cited by 6
Alshehri, M. M., Amjad, M. W., & Mudawi, M. M. E. (2020) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.18311/ajprhc/2020/25518 · Cited by 6
Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers
Kim, J., Sunwoo, J., Song, J. H., Seo, Y.-B., Jung, W. T., Nam, K., Kim, Y., Lee, H., Moon, J., Jung, J. G., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15080962 · Cited by 6
Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C
Sinitsky, M. Y., Асанов, М. А., Sinitskaya, А. V., Shishkova, D. K., Khutornaya, M. V., Minina, V. I., & Ponasenko, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076783 · Cited by 7
Wauquier, F., Boutin-Wittrant, L., Krisa, S., Valls, J., Langhi, C., Otero, Y. F., Sirvent, P., Peltier, S. L., Bargetto, M., Cazaubiel, M., et al. (2023) · Nutrients · doi:10.3390/nu15081903 · Cited by 8
Rodine, R. J., Tibbles, A. C., Kim, P. S., & Alikhan, N. (2010) · Europe PMC (PubMed Central) · Cited by 6
Kadir, N. A. A. A., Azlan, A., Abas, F., & Ismail, I. S. (2018) · Natural Product Communications · doi:10.1177/1934578x1801301205 · Cited by 6
Loss of ULK1 Attenuates Cholesterogenic Gene Expression in Mammalian Hepatic Cells
Rajak, S., Iannucci, L. F., Zhou, J., Anjum, B., George, N., Singh, B. K., Ghosh, S., Yen, P. M., & Sinha, R. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.523550 · Cited by 6
Klementová, Š., Petráňová, P., & Fojtíková, P. (2021) · Open Journal of Applied Sciences · doi:10.4236/ojapps.2021.104035 · Cited by 6
Hsu, M., & Ouyang, W. (2021) · Healthcare · doi:10.3390/healthcare9050545 · Cited by 6
Shahid, R. K., Naik, S. S., Ramphall, S., Rijal, S., Prakash, V., Ekladios, H., Saju, J. M., Mandal, N., Kham, N. I., & Hamid, P. (2022) · Cureus · doi:10.7759/cureus.30942 · Cited by 7
Chauhan, D., Memon, F., Patwardhan, V., Kotwani, P., Shah, P. K., & Venkata, V. S. (2022) · Cureus · doi:10.7759/cureus.31007 · Cited by 6
Differential Sensitivity of the Species of Candida parapsilosis Sensu Lato Complex Against Statins
Szenzenstein, J., Gácser, A., Grózer, Z., Farkas, Z. J., Nagy, K., Vágvölgyi, C., Márki‐Zay, J., & Pfeiffer, I. (2013) · Mycopathologia · doi:10.1007/s11046-013-9689-1 · Cited by 6
Dayyih, W. A., Mallah, E., Al-Ani, I. H., & Arafat, T. (2016) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 6
The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats
Rodríguez-Navarro, S., Raurell, I., Ezkurdia, N., Augustín, S., Esteban, R., Genescà, J., & Martell, M. (2014) · Liver International · doi:10.1111/liv.12472 · Cited by 6
A New Approach to the Treatment of Osteoporosis
Erdemli, B., Kılıçoğlu, B., & Erdemlı, E. (2005) · Orthopedics · doi:10.3928/0147-7447-20050101-15 · Cited by 6
Nawaka, N., Lertcanawanichakul, M., Porntadavity, S., Pussadhamma, B., & Jeenduang, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-00711-1 · Cited by 5
Metabolomic characterization of frailty identifies subtype-specific management strategies
Xiao, L., Deng, Q., Wang, J., Liang, S., Li, R., Cui, H. Z., Li, Y., Jiang, P., Zhang, R., Zeng, L., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02075-2 · Cited by 5
Liu, K., Li, G., Liang, X., Wang, C., Zhu, N., Fu, X., Zhang, Y., Liu, C., & Yang, J. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.036 · Cited by 5
Sucharski, H. C., & Koenig, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_12 · Cited by 6
Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study
Pasha, R., Kamath, A., Linn, Z., Kalteniece, A., Bashir, B., Schofield, J. D., Malik, R. A., Azmi, S., Ferdousi, M., & Soran, H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16617 · Cited by 7
Zhang, S., Rahman, M., Jeppsson, B. W., Herwald, H., & Thorlacius, H. (2013) · Shock · doi:10.1097/shk.0b013e3182844523 · Cited by 5
Zarei, L., Rad, S. M., & Fard, A. A. (2019) · PubMed Central · doi:10.30466/vrf.2019.74079.1996 · Cited by 5
Caffeic Acid Phenethyl Ester: A Potential Anticancer Bioactive Constituent of Propolis
Kapare, H. S., Nagaraj, S., Wakalkar, S., & Rathi, K. (2022) · Current Cancer Therapy Reviews · doi:10.2174/1573394718666220603103458 · Cited by 5
Deciphering Enzyme Mechanisms with Engineered Ancestors and Substrate Analogues
Gao, T., Damborský, J., Janin, Y. L., & Marek, M. (2023) · ChemCatChem · doi:10.1002/cctc.202300745 · Cited by 6
IMPLICATION OF CENTRAL COMPOSITE DESIGN IN THE DEVELOPMENT OF SIMVASTATIN-LOADED NANOSPONGES
Noothi, S., Malothu, N., Areti, A. R., Desu, P. K., & Guguloth, S. K. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.48453 · Cited by 5
Melnychuk, T., Galke, L. P. A., Seidlmayer, E., Bröring, S., Förstner, K. U., Tochtermann, K., & Schultz, C. (2023) · IEEE Transactions on Engineering Management · doi:10.1109/tem.2023.3308008 · Cited by 5
Pan, E., Nielsen, S. J., Landenhed-Smith, M., Törngren, C., Björklund, E., Hansson, E. C., Jeppsson, A., & Martinsson, A. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae007 · Cited by 5
Almeida, G. D. O., Balieiro, C. C. A., Bertoli, E. D., Moreira, M. E. L., Silva, A. L. S., Minucci, B. S., Zapparoli, I. D. A., Maluf, M. S., Carvalho, H. C. P., Borges, R. D. S., et al. (2024) · Coronary Artery Disease · doi:10.1097/mca.0000000000001407 · Cited by 7
Effects of 8-Hydroxyisocapnolactone-2-3-diol and friedelin on mast cell degranulation
Sahid, M. N. A., Nugroho, A. E., Susidarti, R. A., & Maeyama, K. (2017) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2017.10.006 · Cited by 5
Effect of Pitavastatin on Macrophage Cholesterol Metabolism
Akisato, Y., Ishii, I., Kitahara, M., Tamaki, T., Saitō, Y., & Kitada, M. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.357 · Cited by 5
D’Assante, R., Luca, M. D., Ferraro, S., Ferraro, A., Ruvolo, A., Natale, F., Sotgiu, P., Petitto, M., Rizzo, R., Maria, U. D., et al. (2021) · Metabolites · doi:10.3390/metabo11040223 · Cited by 5
Li, S., & Schooling, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-07344-8 · Cited by 8
Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug
Matariek, G., Teibo, J. O., Elsamman, K., Teibo, T. K. A., Olatunji, D. I., Matareek, A., Omotoso, O. E., & Nasr, A. (2022) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2022.4.3.1124 · Cited by 5
Zhang, F., de Bock, G. H., Denig, P., Landman, G. W. D., Zhang, Q., & Sidorenkov, G. A. (2023) · Clinical Epidemiology · doi:10.2147/clep.s386471 · Cited by 5
Góralczyk, K., Soszyńska, K., Haus, O., Bielis, R., & Rość, D. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0012-4 · Cited by 5
The Major Molecular Causes of Familial Hypercholesterolemia
Kim, T. P., Lao, T. D., & Ai, H. L. T. (2018) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.18311/ajprhc/2018/20031 · Cited by 5
Farrag, N. S., & Amin, A. M. (2020) · Nuclear Science and Techniques · doi:10.1007/s41365-020-00819-1 · Cited by 5
PCSK9 Inhibition could be Effective for Acute Myocardial Infarction
Gencer, B., & Mach, F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210804091003 · Cited by 5
Botelho, G. G., Falbo, M. K., Ost, P. R., Czekoski, Z. M., Raviolo, A., Giotto, F., Goldoni, E., & Morais, R. N. (2015) · Journal of animal physiology and animal nutrition · doi:10.1111/jpn.12257 · Cited by 3
Zhao, S., Crouse, W. L., Qian, S., Luo, K., Stephens, M., & He, X. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.509700 · Cited by 5
Spanakis, M., Alon-Ellenbogen, D., Ioannou, P., & Spernovasilis, N. (2023) · Pharmacy · doi:10.3390/pharmacy11040130 · Cited by 3
Kovacic, S., Habicht, S. D., & Eckert, G. P. (2025) · Journal of Nutritional Science · doi:10.1017/jns.2025.10043 · Cited by 4
“(14) Thus, statins intervene very early in the mevalonate metabolic pathway and inhibit the formation of intermediary products including geranylgeranyl pyrophosphate.”
Erbasan, E., Aliciaslan, M., Erendor, F., Şanlioğlu, A. D., & Şanlıoğlu, S. (2025) · Gene Therapy · doi:10.1038/s41434-025-00575-0 · Cited by 5
Yeh, C.-C., Kuo, M., Lee, A.-L., Ma, Y.-S., & Lu, C.-P. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.147932 · Cited by 4
Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases
Commins, I., Clayton‐Chubb, D., Janko, N., Majeed, A., Kemp, W. W., & Roberts, S. K. (2026) · Medical Sciences · doi:10.3390/medsci14010084 · Cited by 4
Edwards, A., Singh, P., Shah, V., Chander, V., & Mishra, S. (2026) · Cells · doi:10.3390/cells15060529 · Cited by 4
Olezarsen and Plozasiran in Dyslipidemia Management: A Narrative Review of Clinical Trials
Olatunji, G. D., Ogieuhi, I. J., Kokori, E., Ajekiigbe, V. O., Ajimotokan, O. I., Odukudu, G.-D. O., Owolabi, S., Anyacho, S., Nwakama, C., Babalola, A. E., et al. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00677-7 · Cited by 4
Hartley, T., Abdelmagid, H., Abdulsalam, Z., Mansion, A., Howe, E., Ramirez, D., White, K., & Tadjuidje, E. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108820 · Cited by 4
Hafiz, A. M., Aljohani, S., Kutbi, H. I., Fatani, N., Alkhathran, L., Alyaqub, M., Alhamed, M. S., Alhaqbani, A. O., Alhadlaq, A. A., Alsalman, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030908 · Cited by 4
Dodulík, J., Plášek, J., Kacířová, I., Uřinovská, R., Vrtal, J., & Václavík, J. (2025) · Pharmaceuticals · doi:10.3390/ph18060818 · Cited by 4
Effect of simvastatin on c-myc, cyclin D1 and p53 expression in DMBA-induced breast cancer in mice
Karimí, B., Ashrafi, M., & Masoudian, M. (2020) · Physiology and Pharmacology · doi:10.32598/ppj.24.2.70 · Cited by 4
Current and emerging drugs for the treatment of atherosclerosis: the evidence to date
Rizvi, A. A., Popovic, D. S., Παπάνας, Ν., Stoian, A. P., Almahmeed, W. A., Sahebkar, A., Janež, A., & Rizzo, M. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2094771 · Cited by 4
Yang, X., Huang, Q., Xu, J., Gao, Z., Jiang, X., Wu, Y., Ye, W., & Yue, L. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15792 · Cited by 4
Hamdy, M. M. A., Korany, M. A., Ebied, S. A., & Haggag, R. S. (2022) · Journal of Planar Chromatography – Modern TLC · doi:10.1007/s00764-022-00201-4 · Cited by 4
Enea, I., & Martelli, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113652 · Cited by 5
Atorvastatin-Loaded Peptide Amphiphiles Against Corneal Neovascularization
Sánchez‐López, E., Gomara, M. J., & Haro, I. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0133 · Cited by 4
What are the benefits and drawbacks of statins in carotid artery disease? A perspective review
Said, S., Dardik, A., & Chaar, C. I. O. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2286011 · Cited by 5
Wei, S., Fu, W.-S., Liu, C.-H., Wang, W.-L., Shih, Y., Chien, S., & Chiu, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2318718121 · Cited by 4
Leite, G. A. A., Lazzari, V. M., Simão, V. A., & Sanabria, M. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2504395 · Cited by 4
Nonenzymatic Mechanism of Statins in Modulating Cholesterol Particles Formation
Madasamy, S., Shivasubramani, U., Villanueva, J., Bigos, M., Amento, E. P., & Wu, A. H. B. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.035 · Cited by 4
Synthesis and Spectroscopic Characterization of Metal Complexes of Rosuvastatin
Tabassum, A., Arayne, M. S., & Sultana, N. (2017) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.51.1.14 · Cited by 4
Bae, H., Cho, Y., Park, H., Yoon, H., Kim, H., Han, S., Hur, S., Kim, Y.-N., Kim, K.-B., Ryu, J.-K., et al. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.272 · Cited by 4
Elkady, E. F., Jaadan, B. M., Ramadan, E., & Elmaaty, A. A. (2022) · Bioanalysis · doi:10.4155/bio-2022-0203 · Cited by 4
Anagnostis, P. G., Kotsis, V., Banach, M., & Mikhailidis, D. P. (2023) · Metabolites · doi:10.3390/metabo13020145 · Cited by 4
Błaszczyk, M., Kozioł, A., Palko-Łabuz, A., Środa-Pomianek, K., & Wesołowska, O. (2023) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2023.184163 · Cited by 4
Kim, D. G., Yim, S. H., Min, E., Choi, M. C., Kim, M. S., Joo, D. J., & Lee, J. G. (2023) · Liver International · doi:10.1111/liv.15653 · Cited by 4
Skouras, P., Κalamatianos, T., Markouli, M., Karagiannis, A. D., & Stavrinou, L. C. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273270503230928100141 · Cited by 4
Li, J., Luo, T. F., Li, X., Liu, X., & Deng, Z. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100630 · Cited by 4
Kansu, B., & Lang, D. (2017) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzx010 · Cited by 4
Atorvastatin regulates pericardial patch healing via the microRNA140-ADAM10-ephrinB2 pathway.
Li, X., Dardik, A., Guo, R., Zhang, W., Xiang, Y., Li, S., Liu, D., & Shu, C. (2018) · Europe PMC (PubMed Central) · Cited by 4
Lusi, S., Lestari, S. R., & Lukiati, B. (2020) · AIP conference proceedings · doi:10.1063/5.0002534 · Cited by 5
Role of Polychlorinated Biphenyls as EDCs in Metabolic Disorders
Hassan, W., Ahmed, H., Murtaza, G., Umar, M. I., & Iqbal, F. M. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-45923-9_11 · Cited by 4
Vahedian‐Azimi, A., Ashtari, S., Alishiri, G. H., Shahriary, A., Isfeedvajani, M. S., Rahimi‐Bashar, F., Panahi, Y., Samadinia, H., Ferdosi, M., Jafari, I., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59261-5_17 · Cited by 4
Liu, C., Lu, H., Yuan, F., Chen, W., Xu, H., Li, H., Hsu, C., Egbuna, O. I., Wu, J., Dias, C. S., et al. (2019) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s208033 · Cited by 4
Caplan, A. I. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231194250 · Cited by 4
Pancreatitis Secondary to Dyslipidemia: An Understudied Condition
Jacobs, T. H., Wayne, C. D., Sajankila, N., & Narayanan, S. (2024) · Lipidology · doi:10.3390/lipidology1020009 · Cited by 3
Zaki, R. M., Ali, M. A. M., Said, M., Chaudhary, A. A., Boufahja, F., Afzal, O., Abu-Elsaoud, A. M., & Halim, A. S. A. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00716-7 · Cited by 3
Rajput, M., Rizvi, S., Pratap, P. D., Raza, S. T., Siddiqi, Z., & Khare, V. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00787-4 · Cited by 3
Weninger, G., Dridi, H., Reiken, S. R., Yuan, Q., Zhao, N., Groom, L. A., Leigh, J., Liu, Y., Tchagou, C., Kang, J., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194490 · Cited by 3
Khushboo, M., & Kothiyal, P. (2013) · Indo American Journal of Pharmaceutical Research · Cited by 3
Dikmen, N., Özkan, H., Açıkgül, F. Ç., ÇAMDEVİREN, B., Emrah, A. Y., AMBARCIOĞLU, P., Duran, N., & YAKIN, A. (2022) · Ankara Üniversitesi Veteriner Fakültesi Dergisi · doi:10.33988/auvfd.938418 · Cited by 3
Zozina, V. I., Kondratenko, S. N., Ших, Е. В., Красных, Л. М., Melnikov, E. S., & Kukes, V. G. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230913133201 · Cited by 3
STATINS: A NEW THERAPEUTIC APPROACH FOR THE TREATMENT OF NEUROPATHIC PAIN
Melkani, I., Kumar, B., Pandey, N. K., Baghel, D. S., & Singh, S. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i5.50456 · Cited by 3
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review